Xcout Intel
Kinoxis Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Kinoxis Therapeutics among drug discovery companies — ranked by similarity to what Kinoxis Therapeutics actually does, not by market-cap band.
Subscribe to see Kinoxis Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Kinoxis Therapeutics
Kinoxis Therapeutics Pty Ltd is an Australian-based, clinical-stage biotechnology company that develops first-in-class therapeutics targeting ALOX15 to address central nervous system (CNS) diseases.
Kinoxis Therapeutics at a glance
Kinoxis Therapeutics is a drug discovery company headquartered in Australia. Xcout tracks 11 named people at Kinoxis Therapeutics, including Cameron Jones (CFO & Company Secretary).
Kinoxis Therapeutics leadership
- Cameron JonesCFO & Company Secretary
- Dr Peter DevineChair
- Hugh AlsopChief Executive Officer, Co-Founder
- Michael BowenChief Scientific Officer, Co-Founder
- Tiina AhveninenVice President, Clinical Research
- Tristan ReekieVice President, Discovery Research
5 more named people on record for Kinoxis Therapeutics, with roles, board committees and tenure — see the full roster →
Top 12 Kinoxis Therapeutics competitors
Ranked by semantic similarity — how close each company is to Kinoxis Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Goldenrod Therapeutics, Inc. is a biotechnology innovator based in Houston, Texas, developing treatments for brain inflammation and PDE4B inhibitors for neurological conditions and substance use disorder.
Similar drug discovery company
Stellate Therapeutics is a pre-clinical stage biotechnology company that develops small molecules produced by human gut bacteria into therapies for neurodegenerative and age-related neurological diseases.
Similar drug discovery company
Senexis Limited is a privately held biotechnology company founded in 2001 that focuses on small-molecule drug development and life sciences research.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Similar drug discovery company
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Similar drug discovery company
Gesynta Pharma AB is a pharmaceutical manufacturing company headquartered in Stockholm, Sweden, dedicated to developing innovative anti-inflammatory and pain-relieving therapies targeting the mPGES-1 enzyme.
Similar drug discovery company
Kainova Therapeutics, formerly known as Domain Therapeutics, is a clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company drives a clinical pipeline of advanced GPCR-modulating therapies to address unmet medical needs.
Similar drug discovery company
COUR Pharmaceuticals is a clinical-stage biotechnology company headquartered in Evanston, Illinois, founded in 2015. The firm focuses on reprogramming the immune system to develop novel treatments for autoimmune diseases.
Similar drug discovery company
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Similar drug discovery company
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Medtech
IAMA Therapeutics is a clinical-stage pharmaceutical and biotechnology company founded in 2021 and headquartered in Genoa, Italy. The firm is dedicated to researching and developing innovative, disease-modifying medicines to treat brain disorders.
Biopharmaceuticals
AgeneBio, Inc. is a development-stage CNS biopharmaceutical company located in Baltimore, Maryland, focused on discovering and developing innovative therapeutics to preserve and restore brain function.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Kinoxis Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Kinoxis Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →